Skip to main content
Log in

ASO Author Reflections: Centralization of Cytoreductive Surgery Alone in Colorectal Peritoneal Metastases Patients: Optimizing Treatment Pathways

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Noiret B, Clement G, Lenne X, et al. Centralization and oncologic training reduce postoperative morbidity and failure-to-rescue rates after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: study on a 10-year national french practice. Ann Surgery. 2020;272(5):847–54. https://doi.org/10.1097/SLA.0000000000004326.

    Article  PubMed  Google Scholar 

  2. van der Ven RGFM, van den Heuvel TBM, Rovers KPB, et al. Towards equal access to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy and survival in patients with isolated colorectal peritoneal metastases: a nationwide population-based study. Ann Surg Oncol. 2024;31:3758. https://doi.org/10.1245/s10434-024-15131-0.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Quenet F, Elias D, Roca L, et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis. Europ J Surg Oncol. 2019;45(2):e17. https://doi.org/10.1016/j.ejso.2018.10.086.

    Article  Google Scholar 

  4. van de Vlasakker VCJ, Lurvink RJ, Cashin PH, et al. The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: a web-based survey and 2021 statement by peritoneal surface oncology group international (PSOGI). Eur J Surg Oncol. 2021;47(11):2888–92. https://doi.org/10.1016/j.ejso.2021.05.023.

    Article  PubMed  Google Scholar 

  5. Noiret B, Lenne X, Bruandet A, Piessen G, Eveno C. Should cytoreductive surgery alone for peritoneal metastases of colorectal origin be centralized? A national study of 4159 procedures. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15180-5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clarisse Eveno MD, PhD.

Ethics declarations

Disclosures

Guillaume Piessen has undertaken consulting work for BMS, Nestlé, Astellas Pharma, MSD, and Daiichi; is a member of the Advisory Board for BMS; and has received travel and accommodation expenses from Medtronic and MSD. Barbara Noiret and Clarisse Eveno have no disclosures to declare that may be relevant to the contents of this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article refers to: Noiret B, Lenne X, Bruandet A, Piessen G, Eveno C. Should Cytoreductive Surgery Alone for Peritoneal Metastases of Colorectal Origin be Centralized? A National Study of 4159 Procedures. Annals Surgical Oncology. Epub 28 Mar 2024. https://doi.org/10.1245/s10434-024-15180-5.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Noiret, B., Piessen, G. & Eveno, C. ASO Author Reflections: Centralization of Cytoreductive Surgery Alone in Colorectal Peritoneal Metastases Patients: Optimizing Treatment Pathways. Ann Surg Oncol (2024). https://doi.org/10.1245/s10434-024-15463-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1245/s10434-024-15463-x

Navigation